BioSig Technologies Inc Share Price Other OTC
Equities
US09073N1028
Advanced Medical Equipment & Technology
Sales 2024 * | 1L 83.45L | Sales 2025 * | 10L 8.34Cr | Capitalization | 1.74Cr 144.85Cr |
---|---|---|---|---|---|
Net income 2024 * | -60L -50Cr | Net income 2025 * | -1.2Cr -100.14Cr | EV / Sales 2024 * | 174 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 17.4 x |
P/E ratio 2024 * |
-2.07
x | P/E ratio 2025 * |
-1.19
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.81% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Hrkac
DFI | Director of Finance/CFO | 58 | 27/02 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 24/09/24 |
Chief Tech/Sci/R&D Officer | 74 | 24/09/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 24/09/24 | |
Frederick Hrkac
DFI | Director of Finance/CFO | 58 | 27/02 |
Steven Abelman
BRD | Director/Board Member | - | 03/05 |
1st Jan change | Capi. | |
---|---|---|
+12.85% | 23TCr | |
+13.88% | 20TCr | |
+18.39% | 14TCr | |
+28.78% | 11TCr | |
+1.67% | 6.49TCr | |
+18.24% | 5.43TCr | |
+7.04% | 5.21TCr | |
+10.83% | 4.52TCr | |
+5.94% | 3.74TCr |